Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus
Conditions
Sponsors
Abbott Diabetes Care Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or over. 2. Type 2 diabetes treated with pre-mixed (biphasic) insulin for at least 6 months prior to study enrolment. 3. Most recent HbA1c less than 7.5% (58 mmol/mol), recorded in medical notes in last 12 months.
Exclusion criteria
Exclusion criteria: 1. Currently prescribed animal insulin. 2. Concomitant disease or condition that may compromise patient safety including and not limited to; cystic fibrosis, severe mental illness, a diagnosed or suspected eating disorder or any uncontrolled long term medical condition. 3. Has a pacemaker or any other neurostimulators. 4. Currently receiving dialysis treatment or planning to receive dialysis during the study. 5. Women who are pregnant, plan to become pregnant or become pregnant during the study. 6. Participating in another study of a glucose monitoring device or drug that could affect glucose measurements or management. 7. Known (or suspected) allergy to medical grade adhesives. 8. In the investigator’s opinion, unsuitable to participate due to any other cause/reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time in hypoglycaemia (<3.9 mmol/L [70 mg/dL]), measured using sensor glucose data collected by the FreeStyle Libre Pro Flash Glucose Monitoring System during the two-week study duration. | — |
Secondary
| Measure | Time frame |
|---|---|
| Other glycaemic measures such as time in range (3.9-10.0 mmol/L [70-180 mg/dL]), measured using sensor glucose data collected by the FreeStyle Libre Pro Flash Glucose Monitoring System during the two-week study duration. | — |
Countries
England, Scotland, United Kingdom
Contacts
Public ContactPamela Reid
Outcome results
None listed